Next Article in Journal
Sclerosing Pneumocytoma: A Ten-Year Experience at a Western Balkan University Hospital
Previous Article in Journal
Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis
Open AccessReview

Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease

1
Department of Biochemistry, College of Biosciences, Federal University of Agriculture, Abeokuta, Nigeria
2
Biochemistry Division, Department of Chemical Sciences, Faculty of Natural Sciences, Ajayi Crowther University, Oyo, Nigeria
*
Author to whom correspondence should be addressed.
Medicina 2019, 55(2), 26; https://doi.org/10.3390/medicina55020026
Received: 5 January 2019 / Accepted: 18 January 2019 / Published: 24 January 2019
Non-alcoholic fatty liver disease (NAFLD) is a term that covers a range of hepatic disorders involving fat deposits in the liver. NAFLD begins with simple steatosis and progresses into non-alcoholic steatohepatitis (NASH) characterised by inflammation, fibrosis, apoptosis, oxidative stress, lipid peroxidation, mitochondrial dysfunction and release of adipokines and pro-inflammatory cytokines. Oxidative stress and antioxidants are known to play a vital role in the pathogenesis and severity of NAFLD/NASH. A number of oxidative stress and antioxidant markers are employed in the assessment of the pathological state and progression of the disease. In this article, we review several biomarkers of oxidative stress and antioxidants that have been measured at clinical and experimental levels. Also included is a comprehensive description of oxidative stress, sources and contribution to the pathogenesis of NAFLD/NASH. View Full-Text
Keywords: liver; NAFLD; NASH; biomarkers; reactive species; oxidative stress; lipid peroxidation; antioxidants liver; NAFLD; NASH; biomarkers; reactive species; oxidative stress; lipid peroxidation; antioxidants
Show Figures

Figure 1

MDPI and ACS Style

Ore, A.; Akinloye, O.A. Oxidative Stress and Antioxidant Biomarkers in Clinical and Experimental Models of Non-Alcoholic Fatty Liver Disease. Medicina 2019, 55, 26.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop